These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 18202963

  • 21. The International Menopause Study of Climate, Altitude, Temperature (IMS-CAT) and vasomotor symptoms.
    Hunter MS, Gupta P, Chedraui P, Blümel JE, Tserotas K, Aguirre W, Palacios S, Sturdee DW.
    Climacteric; 2013 Feb; 16(1):8-16. PubMed ID: 22946508
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of menopausal symptoms in women in Kelantan, Malaysia.
    Dhillon HK, Singh HJ, Shuib R, Hamid AM, Mohd Zaki Nik Mahmood N.
    Maturitas; 2006 Jun 20; 54(3):213-21. PubMed ID: 16326052
    [Abstract] [Full Text] [Related]

  • 23. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms.
    Simon JA, ESTRASORB Study Group.
    Menopause; 2006 Jun 20; 13(2):222-31. PubMed ID: 16645536
    [Abstract] [Full Text] [Related]

  • 24. [Comparison of the frequency and magnitude of the vasomotor symptoms in premenopausal and postmenopausal women from Mexico City].
    Carranza-Lira S, Sandoval-Hernández CI.
    Ginecol Obstet Mex; 2013 Mar 20; 81(3):127-32. PubMed ID: 23672113
    [Abstract] [Full Text] [Related]

  • 25. Minimal decrease in hot flashes desired by postmenopausal women in family practice.
    Butt DA, Deng LY, Lewis JE, Lock M.
    Menopause; 2007 Mar 20; 14(2):203-7. PubMed ID: 17099324
    [Abstract] [Full Text] [Related]

  • 26. The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women.
    Andrikoula M, Baker D, Nesic J, Liao LM, Duka T, Prelevic GM.
    Climacteric; 2011 Oct 20; 14(5):544-50. PubMed ID: 21413865
    [Abstract] [Full Text] [Related]

  • 27. Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women.
    Hedrick RE, Ackerman RT, Koltun WD, Halvorsen MB, Lambrecht LJ.
    Menopause; 2009 Oct 20; 16(1):132-40. PubMed ID: 18971794
    [Abstract] [Full Text] [Related]

  • 28. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
    Utian WH.
    Health Qual Life Outcomes; 2005 Aug 05; 3():47. PubMed ID: 16083502
    [Abstract] [Full Text] [Related]

  • 29. Cyclicity of breast tenderness and night-time vasomotor symptoms in mid-life women: information collected using the Daily Perimenopause Diary.
    Hale GE, Hitchcock CL, Williams LA, Vigna YM, Prior JC.
    Climacteric; 2003 Jun 05; 6(2):128-39. PubMed ID: 12841883
    [Abstract] [Full Text] [Related]

  • 30. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG, Drosman S, Helmond FA, Stathopoulos VM.
    Menopause; 2006 Jun 05; 13(6):917-25. PubMed ID: 17006377
    [Abstract] [Full Text] [Related]

  • 31. Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study.
    Gold EB, Flatt SW, Pierce JP, Bardwell WA, Hajek RA, Newman VA, Rock CL, Stefanick ML.
    Menopause; 2006 Jun 05; 13(3):423-33. PubMed ID: 16735939
    [Abstract] [Full Text] [Related]

  • 32. Insomnia in Japanese peri- and postmenopausal women.
    Terauchi M, Obayashi S, Akiyoshi M, Kato K, Matsushima E, Kubota T.
    Climacteric; 2010 Oct 05; 13(5):479-86. PubMed ID: 19886814
    [Abstract] [Full Text] [Related]

  • 33. Vasomotor menopausal symptoms and risk of cardiovascular disease: a pooled analysis of six prospective studies.
    Zhu D, Chung HF, Dobson AJ, Pandeya N, Anderson DJ, Kuh D, Hardy R, Brunner EJ, Avis NE, Gold EB, El Khoudary SR, Crawford SL, Mishra GD.
    Am J Obstet Gynecol; 2020 Dec 05; 223(6):898.e1-898.e16. PubMed ID: 32585222
    [Abstract] [Full Text] [Related]

  • 34. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women.
    Juang KD, Wang SJ, Lu SR, Lee SJ, Fuh JL.
    Maturitas; 2005 Oct 16; 52(2):119-26. PubMed ID: 16186074
    [Abstract] [Full Text] [Related]

  • 35. Vegans report less bothersome vasomotor and physical menopausal symptoms than omnivores.
    Beezhold B, Radnitz C, McGrath RE, Feldman A.
    Maturitas; 2018 Jun 16; 112():12-17. PubMed ID: 29704911
    [Abstract] [Full Text] [Related]

  • 36. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies.
    Keenan NL, Mark S, Fugh-Berman A, Browne D, Kaczmarczyk J, Hunter C.
    Menopause; 2003 Jun 16; 10(6):507-15. PubMed ID: 14627858
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A pilot study of a Hatha yoga treatment for menopausal symptoms.
    Booth-LaForce C, Thurston RC, Taylor MR.
    Maturitas; 2007 Jul 20; 57(3):286-95. PubMed ID: 17336473
    [Abstract] [Full Text] [Related]

  • 39. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
    Hitchcock CL, Prior JC.
    Menopause; 2012 Aug 20; 19(8):886-93. PubMed ID: 22453200
    [Abstract] [Full Text] [Related]

  • 40. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women.
    Hitchcock CL, Elliott TG, Norman EG, Stajic V, Teede H, Prior JC.
    Menopause; 2012 Nov 20; 19(11):1208-14. PubMed ID: 22781788
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.